| Literature DB >> 24757264 |
Janitha Costa1, Basirat Towobola2, Cliona McDowel3, Robin Ashe2.
Abstract
Entities:
Mesh:
Year: 2014 PMID: 24757264 PMCID: PMC3992089
Source DB: PubMed Journal: Ulster Med J ISSN: 0041-6193
Cohort characteristics at the time of index surgery
| Characteristic | Sample N=114 |
|---|---|
| Age (Mean(SD)) | 53.93(12) |
| Body Weight in Kg (Mean(SD)) | 70.48(16.2) |
| Vaginal parity (Mean(SD)) | 3.16(1.8) |
| Menopausal status N(%) | |
| Pre-menopausal | 44(38.6) |
| Post menopausal | 70(61.4) |
| Chronic lung disease N(%) | 10(8.8) |
| Chronic steroid use N(%) | 4(3.5) |
| Race N(%) | |
| Caucasian | 113(99.13) |
| Other | 1(0.9) |
| Surgery Indication N(%) | |
| Menorrhagia only | 14(12.3) |
| Prolapse only | 59(51.8) |
| Prolapse and menorrhagia | 15(13.2) |
| Prolapse and Incontinence | 26(22.8) |
| Index Surgery N(%) | |
| VH | 27(23.7) |
| VH & AR | 33(28) |
| VH & PR | 9(7.9) |
| VH, AR & PR | 45(39.5) |
| Years of Follow Up (Mean(SD)) | 9.18(1.9) |
Preoperative prolapse severity according to the site involved
| Anterior Compartment N(%) | Posterior Compartment N(%) | Apex N(%) | Overall Stage N(%) | |
|---|---|---|---|---|
| No Prolapse | 14 (12.3) | 47 (41.2) | 0 | 0 |
| Grade 1 | 35 (30.7) | 34 (29.8) | 47 (41.2) | 23 (20.2) |
| Grade 2 | 58 (50.9) | 30 (26.3) | 63 (55.3) | 82 (71.9) |
| Grade 3 | 7 (6.1) | 3 (2.6) | 4 (3.5) | 9 (7.9) |
| Not assigned | 0 | 0 | 0 | 0 |
Nature of recurrent POP (subjective) according to the site and time to appear
| same site n(%) | new site n(%) | time interval between index operation and the recurrent Poo in years Mean(sd) | |
|---|---|---|---|
| Apex | 6 (24%) | 0 | 3.5(0.55) |
| Anterior compartment | 8 (32%) | 4 (16%) | Same site 4.46(2.2) New site 4.23 |
| Posterior compartment | 2 (8%) | 5(20%) | Same site 5(1.4) New site 5.25(1.25) |
Comparison of characteristic between subjective recurrence (n=18) and no subjective recurrence (n=96)
| Characteristic | No subjective recurrence n=96 | Aubjective recurrence n=18 | P value |
|---|---|---|---|
| Age (Mean(SD)) | 53.67(12.15) | 55.33(11.59) | 0.58 |
| Body Weight in Kg (Mean(SD)) | 70.85 | 68.55(11.84) | |
| Vaginal parity (Mean(SD)) | 3.15 | 3.33(1.37) | |
| Menopausal status N(%) | |||
| Pre-menopausal | 38(39.6) | 6(33.3) | 0.79 |
| Post menopausal | 58(60.4) | 12(66.7) | |
| Chronic lung disease & steroid use % | 8.3 | 11.1 | |
| Race N(%) | |||
| Caucasian | 95(99.0) | 18(100.0) | |
| Other | 1(1.0) | 0(0.0) | |
| Surgery Indication N(%) | |||
| None Prolapse(Menorrhagia ) | 14(14.6) | 0(0.0) | 0.22 |
| Prolapse +/- other | 82(85.4) | 18(100%) | |
| Index Surgery N(%) | |||
| VH | 26(27.1) | 1(5.5) | 0.09 |
| VH + Colporrhaphy | 70(73.0) | 17(94.5) |
P-value from Independent t-test presented.
All other p-values presented are from the Fishers Exact Test
Characteristics of patients with objective recurrence (n=19)compared with no objective recurrence (n=39)
| Characteristic | No anatomical recurrence n=39 | Objective recurrence n=19 | P value |
|---|---|---|---|
| Age (Mean(SD)) | 51.5(11.23) | 58.9( 9.60) | 0.01 |
| BodyWeight in Kg (Mean(SD) | 69.5(15.89) | 73.3(17.90) | 0.43 |
| Vaginal Parity (Mean(SD) | 3.3(1.90) | 2.8(1.13) | 0.25 |
| Menopausal status N(%) | |||
| Pre-menopausal | 19(48.7) | 3(15.8) | 0.02 |
| Post menopausal | 20(51.3) | 16(84.2) | |
| Surgery Indication N(%)% | |||
| None Prolapse (Menorrhagia) | 6(15.4) | 0(0.0) | 0.08 |
| Prolapse +/- Other | 30(84.6) | 19(100) | |
| Index Surgery N(%) | |||
| VH | 12(30.8) | 2(10.5) | 0.32 |
| VH & Colporrhaphy | 27(69.2) | 17(89.5) |
Independent Sample t-test used
*Statistically Significant Result